Search Results

Displaying Results 6851-6875 of 10401 "'ID'"

Oct 16, 2025, 09:00 ET KBR, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - KBR

https://securitiesclasslaw.com/securities/kbr-inc-loss-submission-form/?id=172038&from=4  CLASS PERIOD: May 6, 2025 to June 19, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET Investors who lost money on Dow Inc.(DOW) should contact The Gross Law Firm about pending Class Action - DOW

https://securitiesclasslaw.com/securities/dow-inc-loss-submission-form/?id=172029&from=4  CLASS PERIOD: January 30, 2025 to July 23, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET LifeMD, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMD

https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=172028&from=4  CLASS PERIOD: May 7, 2025 to August 5, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET SVRA LAWSUIT ALERT: The Gross Law Firm Notifies Savara Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

https://securitiesclasslaw.com/securities/savara-inc-loss-submission-form/?id=172032&from=4 CLASS PERIOD: March 4, 2024 to May

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET The Gross Law Firm Notifies Fortinet, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - FTNT

https://securitiesclasslaw.com/securities/fortinet-inc-loss-submission-form/?id=172040&from=4  CLASS PERIOD: November 8, 2024 to August 6, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2025 in Snap Inc. Lawsuit - SNAP

https://securitiesclasslaw.com/securities/snap-inc-loss-submission-form-3/?id=172024&from=4 CLASS PERIOD: April 29, 2025 to August

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET Contact The Gross Law Firm by November 14, 2025 Deadline to Join Class Action Against Fluor Corporation(FLR)

https://securitiesclasslaw.com/securities/fluor-corporation-loss-submission-form/?id=172036&from=4  CLASS PERIOD: February 18, 2025 to July 31, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET WPP plc Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 8, 2025 to Discuss Your Rights - WPP

https://securitiesclasslaw.com/securities/wpp-plc-loss-submission-form/?id=172041&from=4  CLASS PERIOD: February 27, 2025 to July 8, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET The Gross Law Firm Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK

https://securitiesclasslaw.com/securities/cytokinetics-incorporated-loss-submission-form/?id=172037&from=4  CLASS PERIOD: December 27, 2023 to May 6, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET The Gross Law Firm Notifies Shareholders of Nutex Health Inc.(NUTX) of a Class Action Lawsuit and an Upcoming Deadline

https://securitiesclasslaw.com/securities/nutex-health-inc-loss-submission-form/?id=172027&from=4  CLASS PERIOD: August 8, 2024 to August 14, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET The Gross Law Firm Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 - ATYR

https://securitiesclasslaw.com/securities/atyr-pharma-inc-loss-submission-form/?id=172042&from=4  CLASS PERIOD: January 16, 2025 to September 12,

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET Shareholders that lost money on C3.ai, Inc.(AI) should contact The Gross Law Firm about pending Class Action - AI

https://securitiesclasslaw.com/securities/c3-ai-inc-loss-submission-form-2/?id=172026&from=4  CLASS PERIOD: February 26, 2025 to August 8, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET The Gross Law Firm Reminds V.F. Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 12, 2025 - VFC

https://securitiesclasslaw.com/securities/v-f-corporation-loss-submission-form/?id=172035&from=4  CLASS PERIOD: October 30, 2023 to May 20, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET The Gross Law Firm Reminds Tronox Holdings plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 3, 2025 - TROX

https://securitiesclasslaw.com/securities/tronox-holdings-plc-loss-submission-form-2/?id=172031&from=4  CLASS PERIOD: February 12, 2025 to July 30, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET Fly-E Group, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before November 10, 2025 to Discuss Your Rights - FLYE

https://securitiesclasslaw.com/securities/fly-e-group-inc-loss-submission-form/?id=172034&from=4  CLASS PERIOD: July 15, 2025 to August 14, 2025

More news about: Gross Law Firm


Oct 16, 2025, 09:00 ET MFour Introduces Full-Funnel iOOH™ Attribution for Out-of-Home Advertising

validated using MFour's opted-in, location-enabled consumer panel and connected to outcomes across app, web, and location via MFour's unified consumer ID. The new iOOH™ Attribution add-on specifically quantifies behavioral change - linking exposure to user-level app activity,

More news about: MFour Data Research


Oct 16, 2025, 09:00 ET The Creator Economy Shift: Why More Creators Are Moving Away from Mainstream Platforms and Choosing RM11 for Direct Monetization

content, and private fan interactions, turning casual followers into a premium, engaged fanbase. "It's direct-to-fan in the truest sense," she adds. "I'd rather have 100 fans who pay for direct access and trust me, than millions who might never see my content." Her success mirrors

More news about: RM11.com


Oct 16, 2025, 08:30 ET SuperCom Expands Utah Presence with Second New Contract Win This Year

enrollment, personalization, issuance, and border control services, SuperCom has inspired governments and national agencies to design and issue secure Multi-ID documents and robust digital identity solutions to its citizens and visitors. SuperCom offers a unique all-in-one field-proven RFID & mobile technology

More news about: SuperCom


Oct 16, 2025, 08:04 ET CGTN: Tiongkok Dorong Pencapaian Baru dalam Pemberdayaan Perempuan di Dunia

https://news.cgtn.com/news/2025-10-13/China-leads-global-push-for-a-new-milestone-in-women-s-development-1Hr25ID2HtK/p.html

More news about: CGTN


Oct 16, 2025, 08:00 ET Semperis Announces Midnight in the War Room: A Groundbreaking Cyberwar Documentary Featuring the World's Leading Defenders and Reformed Hackers

charged with defending hybrid and multi-cloud environments. Purpose-built for securing hybrid identity environments—including Active Directory, Entra ID, and Okta—Semperis' AI-powered technology protects over 100 million identities from cyberattacks, data breaches, and operational errors.

More news about: Semperis


Oct 16, 2025, 07:00 ET Anywhere to Release Third Quarter 2025 Financial Results and Host Webcast on November 4, 2025

Event Registration Page, at which time registrants will receive dial-in information as well as a conference ID. Registration can be completed in advance of the conference call. About Anywhere Real Estate Inc.

More news about: Anywhere Real Estate Inc.


Oct 16, 2025, 07:00 ET Canadian Solar Schedules Third Quarter 2025 Earnings Conference Call for November 13

U.S.), 800 905 945 (from Hong Kong), 400 120 1203 (local dial-in from Mainland China) or +1-412-317-6026 from international locations. The conference ID is 10203526. A live webcast of the conference call will also be available on the investor relations section of Canadian Solar's website at

More news about: Canadian Solar Inc.


Oct 16, 2025, 06:05 ET Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options

company updates. Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic

More news about: Biocon Biologics


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.